Table of Contents Table of Contents
Previous Page  312 / 435 Next Page
Information
Show Menu
Previous Page 312 / 435 Next Page
Page Background

GUIDANC

Method A

ERP First A

recomme

implemen

Draft Fina

Safety Con

Reference

Single Lab

Reproduc

Probabilit

Compariso

Feedback 

DOCUMEN

Safety Eva

Reference

SLV or PTM

Approved

Statistics R

Method P

Method P

Feedback 

Additiona

ERP Repor

Manuscrip

ERP Meth

(Final Acti

1

Official Method

to Evaluate Char

AOAC 201

ERP SUM

E FOR AOAC 

pplicability 

ction to Fina

ndations & im

ted/addresse

l Action meth

cerns 

 Materials 

oratory Valid

ibility/Uncert

y of Detection

n to SMPR (

from Users o

TATION

luation 

 Materials 

 Validation Pr

eview 

ublished in O

erformance v

Information 

l Recognition

ts 

t(s) Publishe

od Recomme

on/Repeal/C

s of Analysis of A

acteristics of a Me

2.22

MARY FOR F

ERPS ‐ APPEN

l Action 

provements

od reviewed

ation 

aintyand 

SMPR criteria 

f Method 

otocols 

MA 

s SMPR crite

(s) 

d in JAOAC 

ndation  

ontinuation)

OAC INTERNATION

thod of Analysis, 

Vitamin C in

IRST TO FIN

DIX G

1

Con

Yes

Yes

 by ERP Yes

Yes

Yes

Yes

Yes

met?)

Yes

Yes

Ava

Yes

Yes

Yes

Yes

Yes

Yes

ria 

Yes

Yes

No

Yes

Yes

Yes

AL

, Appendix G: 

p.3 “

First Action t

 Infant Form

AL ACTION 

sidered?

C

E

S

E

a

c

2

Ju

A

N

G

E

R

Se

R

a

A

ilable?

C

C

  N

N

su

U

R

w

C

A

A

in

N

D

S

M

G

E

R

Procedures and G

o Final Action Met

ula and Adu

METHOD RE

omments/Re

RP satisfied wi

MPR.  See ERP

RP comments

ddressed with

omments duri

016.

ne 2016; See 

ll issues resolv

IST SRM 1849a

iménez et al., 

RP report for A

eviewed in Ma

e ERP reports

eviewed in Sep

nd March 2016

ddressed, no a

omments

ompleted duri

IST SRM 1849a

ot published, 

bmitted for E

sed SMPR; OM

esource Pages

orking group c

ompleted duri

OAC 2012.22

OAC SMPR 20

 Infant Formu

utritional Form

iscussed durin

eptember 201

arch 2016 

iménez et al., 

RP report fro

ecommenda

uidelines for the U

hods: Guidance fo

lt/Pediatric N

COMMEND

ference if ap

th applicability

 reports 

 during March 

 additional wo

ng review for F

draft of metho

ed 

; SPIFAN mat

J. AOAC Int.

96

ugust 17, 201

rch 2015, and

tember 2012,

dditional feed

ng ERP meetin

; SPIFAN Mat

but ERP review

RP review July

A Appendix D

; Assistance fr

hair. 

ng ERP meetin

12.012 – SMPR

la and Adult/P

ula 

g ERP meeting

2, August 201

J. AOAC Int.

96

m March 201

tion; See dra

se of AOAC Volu

r AOAC Expert Re

utritional Fo

ATION

plicable

 omparability

2015.  Comme

rk.  No additio

inal Action in 

rices 

, 1065(2013);

3. 

 March 2016 b

 March 2015, 

back submitte

rices 

ed report,  

 2013 

; SPIFAN 

om ERP chair, 

 for Vitamin C

ediatric 

3, March 2015

, 1065(2013)

6 – Final Act

ft of method

ntary Consensus S

view Panels.” 

rmula 

 to 

nts 

nal 

March 

y ERP; 

ion 

tandards 

AOAC OMB Meeting Book

295